Local opioids in a model of periodontal disease in rats

Archives of Oral Biology

Volumn 52, Issue 7, 2007, Pages 677-683

  Pacheco, Cinthia M F ^a   Queiroz Jr , Celso M ^a   Maltos, Kátia L M ^a   Caliari, Marcelo V ^a   Rocha, Orivaldo A ^a   Francischi, Janetti N ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Alveolar bone crest; Fiber attachment; Inflammation; Opioids; Periodontal disease

Indexed keywords

ANTIINFLAMMATORY AGENT; MORPHINE; NALTREXONE; NARCOTIC ANTAGONIST; OPIATE RECEPTOR;

ANIMAL; ARTICLE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GINGIVA; INJECTION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; OSTEOLYSIS; PATHOLOGY; PERIODONTAL DISEASE; RAT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ALVEOLAR BONE LOSS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GINGIVA; INJECTIONS; INJECTIONS, SUBCUTANEOUS; LEUKOCYTE COUNT; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NEUTROPHILS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

RATTUS;

EID: 34247867997     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2006.12.012     Document Type: Article

References (29)

1. 2 levels as a predictor of periodontal attachment loss. J Periodontal Res 21 (1986) 101-112
2. Lohinai Z., Stachlewitz R., Virag L., Székely A.D., Hasko G., and Szabó C. Evidence for reactive nitrogen species formation in the gingivomucosal tissue. J Dent Res 80 (2001) 470-475
3. Györfi A., Fazekas A., Suba Zs., Ender F., and Rosivall L. Neurogenic component in ligature-induced periodontitis in the rat. J Clin Periodontol 21 (1994) 601-605
4. Sibinga N.E.S., and Goldstein A. Opioid peptides an opioid receptors in cells of the immune system. Annu Rev Immunol 6 (1988) 219-249
5. Joris J., Costello A., Dubner R., and Hargreaves K.M. Opiates suppress carrageenan-induced oedema and hyperthermia at doses that inhibit hyperalgesia. Pain 42 (1990) 95-103
6. Wilson J.L., Nayanar V., and Walker J.S. The site of anti-arthritic action of the κ-opioid, U-50,488H, in adjuvant arthritis: importance of local administration. Br J Pharmacol 118 (1996) 1754-1760
7. Walker J.S., Chandler A.K., Wilson J.L., Binder W., and Day R.O. Effects of μ-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats. Inflamm Res 45 (1996) 557-563
8. Stein C., Schäfer M., and Hassan A.H.S. Peripheral opioid receptors. Ann Med 27 (1995) 219-221
9. Stein C., Schäfer M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med 9 (2003) 1003-1008
10. Sallay K., Sanavi F., Ring I., Pham P., Behling U.H., and Nowotny A. Alveolar bone destruction in the immunosuppressed rat. J Periodontal Res 17 (1982) 263-274
11. Maltos K.L.M., Menezes G.B., Caliari M.V., Rocha O.A., Santos J.M.M., Alves D.L.F., et al. Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp. Arch Oral Biol 49 (2004) 443-450
12. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
13. Mochizuki K., Yamaguchi M., and Abiko Y. Enhancement of LPS-stimulated plasminogen activator production in aged gingival fibroblasts. J Periodontal Res 34 (1999) 251-260
14. Van Der Velden U. Effect of age on the periodontium. J Clin Periodontol 11 (1984) 281-294
15. Lohinai Z., Benedek P., Rosivall L., Fehér E., Györfi A., Fazekas A., et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase in ligature-induced periodontitis in the rat. Br J Pharmacol 123 (1998) 353-360
16. Breivik T., Opstad P.K., Gjermo P., and Thrane P.S. Effects of hypothalamic-pituitary-adrenal axis reactivity on periodontal tissue destruction in rats. Eur J Oral Sci 108 (2000) 115-122
17. Nociti Jr. F.H., Nogueira-Filho G.R., Tramontina V.A., Machado M.A.N., Barros S.P., et al. Histometric evaluation of the effect of nicotine administration on periodontal breakdown: an in vivo study. J Periodontal Res 36 (2001) 361-366
18. Klausen B. Microbiological and immunological aspects of experimental periodontal disease in rats: a review article. J Periodontol 62 (1991) 59-73
19. Muller W.A. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest 82 (2002) 521-533
20. Gemmell E., Yamazaki K., and Seymour G.J. Destructive periodontitis lesions are determined by the nature of the lymphocyte response. Crit Rev Oral Biol Med 13 (2002) 17-34
21. Van Dyke T.E., and Serhan C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal disease. J Dent Res 82 (2003) 82-90
22. 4 inhibits leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxigenase-2 and lipoxins in periodontal disease. Biochemistry 39 (2000) 4761-4768
23. Daniel M.A., and Van Dyke T.E. Alterations in phagocyte function and periodontal infection. J Periodontol 67 (1996) 1070-1075
24. Barber A. μ- and κ-opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin. Eur J Pharmacol 236 (1993) 113-120
25. Pol O., Alameda F., and Puig M.M. Inflammation enhances μ-opioid receptor transcription and expression in mice intestine. Mol Pharmacol 60 (2001) 894-899
26. Zöllner C., Shaqura M.A., Bopaiah C.P., Mousa S., Stein C., and Schäfer M. Painful inflammation-induced increase in μ-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64 (2003) 202-210
27. Lima V., Bezerra M.M., Alencar V.B.M., Vidal F.D.P., Rocha F.A.C., Brito G.A.C., et al. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 108 (2000) 123-129
28. Weinberg M., and Bral M. Laboratory animal models in periodontology. J Clin Periodontol 26 (1999) 335-340
29. Hassan A.H.S., Ableitner A., Stein C., and Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55 (1993) 185-195